bioXXmed AG reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was EUR 0.012233 million compared to EUR 0.044626 million a year ago. Net loss was EUR 0.829837 million compared to EUR 4.06 million a year ago.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.462 EUR | 0.00% |
|
-11.15% | +3.59% |
2023 | BioXXmed AG Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
2023 | BioXXmed AG Reports Earnings Results for the Full Year Ended December 31, 2022 | CI |
1st Jan change | Capi. | |
---|---|---|
+3.59% | 25.35L | |
+23.13% | 4.69TCr | |
+37.21% | 3.91TCr | |
-8.73% | 3.85TCr | |
+28.09% | 3.1TCr | |
-12.26% | 2.61TCr | |
+10.57% | 2.59TCr | |
+45.05% | 1.42TCr | |
+32.23% | 1.25TCr | |
-6.56% | 1.14TCr |
- Stock Market
- Equities
- T5O Stock
- News bioXXmed AG
- BioXXmed AG Reports Earnings Results for the Full Year Ended December 31, 2022